Home -- Symptoms -- Cycles -- References


References

Agger WA, Callister SM, Jobe DA, In vitro susceptibilities of Borrelia burgdorferi to five oral cephalosporins and ceftriaxone, Antimicrob Agents Chemother 1992; Aug;36(8):1788-90.

Ball P, The self-made tapestry: pattern formation in nature, Oxford University Press, Oxford, New York, Tokyo, 1999. (look inside book)

Barkley M, Harris N, Szantyr B, 1997. The Lyme Urine Antigen Test (LUAT) during antibiotic therapy in women with recurrent menstrual cycles. 10th Annual Int. Conf. on Lyme Borreliosis, National Institute of Health, Bethesda, MD, April 28-30.

Beck G, Habicht GS, Benach JL, Coleman JL, Lysik RM, O'Brien RF, A role for interleukin-1 in the pathogenesis of Lyme disease. Zentralbl Bakteriol Mikrobiol Hyg [A] 263(1-2):133-6 , 1986.

Bingen E, Goury V, Bennani H, Lambert-Zechovsky N, Aujard Y, Darbord JC, Bactericidal activity of beta-lactams and amikacin against Haemophilus influenzae: effect on endotoxin release. J. Antimicrob. Chemother. 30:165-172, 1992.

Bleiweiss JD, When to Suspect Lyme Disease?

Bransfield RC, Sex & Lyme.

Bristol-Myers Squibb, Pharmaceutical Information, 777 Scudders Mill Road Plainsboro, NJ 08536, Tel.: +1 (609) 252-4000 or (800) 332 - 2056.

Brorson O, Brorson SH, In vitro conversion of Borrelia burgdorferi to cystic forms in spinal fluid and transformation to mobile spirochetes by incubation in BSK-H medium. Infection 26:144-150, 1998.

Bericht des Landeshygiene-Instituts Mecklenburg-Vorpommern, Schloßstraße 8, D - 17235 Neustrelitz, Tel. + 49 -3981- 272 - 100 (Dr. Kober), 1997.

Burns MJ, Furie MB, Borrelia burgdorferi and Interleukin-1 Promote the Transendothelial Migration of Monocytes In Vitro by Different Mechanisms, Infect Immun 66: 4875-4883, 1998.

Burrascano JJ, The new Lyme disease: diagnostic hints and treatment guidelines for tick-borne illnesses.

Buxton Hopkin DA., Too rapid destruction of gram-negative organisms. Lancet i:603-604, 1977.

Chambers HF, Hadley WK, Jawetz E, "Beta-lactam antibiotics & other inhibitors of cell wall synthesis", pages 725-726 in: Basic & Clinical Pharmacology (Katzung BG, ed.), Appleton & Lange, Stamford, CT, USA, 1998.

Cohen J, and McConnell JS, Antibiotic-induced endotoxin release. Lancet i:1089-1090, 1985. (Letter).

Cohen, J, and McConnell JS, Release of endotoxin from bacteria exposed to ciprofloxacin and its prevention with polymixin B. Eur. J. Clin. Microbiol. 5:13-17, 1986.

Crosby HA, Bion JF, Penn CW, and Elliott TSJ, Antibiotic-induced release of endotoxin from bacteria in vitro. J. Med. Microbiol. 40:23-30, 1994.

Coyle, PK, Borrelia burgdorferi infection: clinical diagnostic techniques. Immunol Invest 1997 Jan; 26(1&2):117-128

Damas P Ledoux D, Nys M , Vrindts Y, De Groote D, Franchimont P, and Lamy M., Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann. Surg. 215:356Ð362, 1992.

De Boer RJ, Perelson AS, Kevrekidis IG, Immune network behavior--I. From stationary states to limit cycle oscillations., Bull Math Biol 55(4):745-80, 1993.

Dever LL, Torigian CV, and Barbour AG, In Vitro activities of the everninomicin SCH 27899Êand other newer antimicrobial agents against Borrelia burgdorferi, Antimicrob Agents Chemother. 43(7): 1773-17, 1993 (Abstract, full text).

Dibrov BF, Livshits MA, Vol'kenshtein MV, Mathematical model of the immune response, Biofizika 1976 Sep-Oct;21(5):905-9, 1976.

Dibrov BF, Livshits MA, Vol'kenshtein MV, Mathematical model of the immune response. IV. Threshold character of the infectious process, Biofizika 1978 Jan-Feb;23(1):143-7, 1978.

Dotevall L, Alestig K, Hanner P, Norkrans G, Hagberg L, The use of doxycycline in nervous system Borrelia burgdorferi infection.Scand J Infect Dis Suppl 1988;53:74-9.

Dotevall L, Hagberg L, Penetration of doxycycline into cerebrospinal fluid in patients treated for suspected Lyme neuroborreliosis. Antimicrob Agents Chemother 1989 Jul;33(7):1078-80.

Eng RHK, Smith SM, Fan-Havard P, and Ogbara T, 1993. Effect of antibiotics on endotoxin release from gram-negative bacteria. Diagn. Microbiol. Infect. Dis. 16:185-189.

Evans ME, Pollack M, Effect of antibiotic class and concentration on the release of lipopolysaccharide from Escherichia coli. J. Infect. Dis. 167:1336-1343, 1993.

Fallon BA, Nields JA, Microbiology of Borrelia burgdorferi, in: "Lyme Disease: A Neuropsychiatric Illness", an overview, The American Journal of Psychiatry 1994;151,11:1571-1583.

Friedland IR, Jafari H, Ehrett S, Rinderknecht S, Paris M, Coulthard M, Saxen H, Olsen K, and McCracken GH, Comparison of endotoxin release by different antimicrobial agents and the effect on inflammation in experimental Escherichia coli meningitis. J. Infect. Dis. 168:657-662, 1993.

Frieling JTM, Mulder JA, Hendrics T , Curfs JHAJ, van der Linden CJ, Sauerwein RW, Differential Induction of Pro- and Anti-Inflammatory Cytokines in Whole Blood by Bacteria: Effects of Antibiotic Treatment, Antimicrobial Agents and Chemotherapy 35:1439Ð1443, 1997.

Frieling JTM, Van Deuren M, Wijdenes J, Van der Meer JWM, Clement C, Van der Linden C, and Sauerwein RW, Circulating interleukin-6 receptor in patients with sepsis syndrome. J. Infect. Dis. 171:469Ð472, 1995. (see also Frieling et al 1997)

Giambartolomei GH, Dennis VA, Philipp MT, Borrelia burgdorferi stimulates the production of interleukin-10 in peripheral blood mononuclear cells from uninfected humans and rhesus monkeys, Infect Immun Jun;66(6):2691-7, 1998.

Goodman and Gilman's "The Pharmacological Basis of Therapeutics, 9th ed., McGraw Hill, 1995, abstracting this value from Schaad et al., 1990.

Groer M, Carr J, Younger MS, Relationships between self-reported symptoms of infection, menstrual-cycle-related distress, and cycle phase. Behav Med 1993 Spring;19(1):13-9, 1993.

Heinemann M, Trautmann M, Sepsis und Antibiotika-induzierte Freisetzung von Endotoxinen: Konsequenzen für die Therapie? ChemotherapieJournal, 8. Jahrgang, Heft 5, 1999.

Hemmer B, et al. Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease. Nature Medicine 5(12):1375-82, 1999.

Hu LT, Klempner MS, Host-pathogen interactions in the immunopathogenesis of Lyme disease. J Clin Immunol 17(5):354-65, 1997.

Hurley JC, Antibiotic-induced release of endotoxin: a reappraisal. Clinical Infectious Diseases 1992;15:840-854.

Karlsson M, Hammers S, Nilsson-Ehle I, Malmborg AS, Wretlind B, Concentrations of doxycycline and penicillin G in sera and cerebrospinal fluid of patients treated for neuroborreliosis. Antimicrob Agents Chemother 1996 May;40(5):1104-7.

Kazragis RJ, Dever LL, Jorgensen JH, Barbour AG. In vivo activities of ceftriaxone and vancomycin against Borrelia spp. in the mouse brain and other sites. Antimicrob Agents Chemother. 1996 Nov;40(11):2632-6 (Abstract, full text).

Kessler RE, Fung-Tomc J, Susceptibility of bacterial isolates to beta-lactam antibiotics from U.S. clinical trials over a 5-year period, Am J Med 1996;100(suppl 6A):13S-19S.

Klempner MS and Huber BT, Is it thee or me?-autoimmunity in Lyme disease. Nature Medicine 5(12):1346-7, 1999.

Kossmann T, Hans V, Stocker R, Imhof HG, Joos B, Trentz O, Morganti-Kossmann MC, Penetration of cefuroxime into the cerebrospinal fluid of patients with traumatic brain injury. J Antimicrob Chemother 37:161-7, 1996.

Kuby J, Immunology, 3rd Ed., WH Freeman and Co, New York, 1997.

Lawrence C, Lipton RB, Lowy FD, Coyle PK, Seronegative chronic relapsing neuroborreliosis. Eur Neurol 1995;35(2):113-117.

Leslie CA, Dubey DP, Increased PGE2 from human monocytes isolated in the luteal phase of the menstrual cycle. Implications for immunity?, Prostaglandins 1994 Jan;47(1):41-54.

Ma Y, Weis JJ, Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties. Infect Immun 1993 Sep;61(9):3843-53.

Mattie H, Antibiotic efficacy in vivo predicted by in vitro activity, Internat J Antimicrob Agents 14:91-98, 2000.

Mattman, LH, Cell Wall Deficient Forms - Stealth Pathogens, 2nd. ed., CRC Press, 1993.

McConnell, J. S., and J. Cohen, Release of endotoxin from Escherichia coli by quinolones. J. Antimicrob. Chemother 18:765-766, 1986. (Letter).

McKenzie FE, Bossert WH, The dynamics of Plasmodium falciparum blood-stage infection, J Theor Biol. 188(1):127-40, 1997.

Mertsola, J., O. Ramilo, M. M. Mustafa, X. Saez-LLorens, E. J. Hansen, and G. H. McCracken, Release of endotoxin after antibiotic treatment of gram-negative bacterial meningitis. Pediatr. Infect. Dis. J. 8:904-906, 1989.

Mohler, J. B. Fantin, J. L. Mainardi, and C. Carbon, Influence of antimicrobial therapy on kinetics of tumor necrosis factor levels in experimental endocarditis caused by Klebsiella pneumoniae. Antimicrob. Agents Chemother. 38:1017-1022, 1994.

Muraille E, Thieffry D, Leo O, Kaufman M, Toxicity and neuroendocrine regulation of the immune response: a model analysis, J Theor Biol. 183(3):285-305, 1996.

Nau R et al., Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meninges. Antimicrob Agents Chemother 37:1518-1524, 1993.

Northern AL, Rutter SM, Peterson CM, Cyclic changes in the concentrations of peripheral blood immune cells during the normal menstrual cycle. Proc Soc Exp Biol Med Oct;207(1):81-8, 1994.

Phillips SE, Mattman LH, Hulinska D, Moayad H, A Proposal for the reliable culture of Borrelia burgdorferi from patients with chronic Lyme disease, even from those previously aggressively treated, Infection 26 (1998) 364-367.

Preac-Mursic V, Wilske B, Schierz G, Holmburger M, Süß E, In vitro and in vivo susceptibility of Borrelia burgdorferi, Europ J Clin Microbiol 6:424-426, 1987.

Preac-Mursic V, Weber K, Pfister HW, Wilske B, Gross B, Baumann A, Prokop J, Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis. Infection Nov-Dec;17(6):355-9, 1989.

Preac-Mursic V, Wilske B, Schierz G, Süß E, Comparative antimicrobial activity of new macrolides against Borrelia burgdorferi. Europ J clin Microbiol Infect Dis 8:651-653, 1989.

Preac-Mursic V, Marget W, Busch U, Pleterski D, Rigler S, Hagl S , Kill Kinetics of Borrelia burgdorferi, Infection, 24: 9 - 16, 1996.

Preac Mursic V, Wanner G, Reinhardt S, Busch U, Marget W, Formation and cultivation of Borrelia burgdorferi spheroplast-L-form variants. Infection 24 (1996): 218-226.

Roumen RMH., Frieling JT M , van Tits HWHJ , van der Vliet JA, and Goris RJA, Endotoxemia following major vascular operations. J. Vasc. Surg. 18:853-857, 1993.

Samples taken from 43 year old female whose data were analyzed in this report.

Schaad UB, Suter S, Gianella-Borradori A, Pfenninger J, Auckenthaler R, Bernath O, Chesaux JJ, and Wedgwood J, A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children. N. Engl. J. Med. 322:141-147, 1990.

Sellati TJ, Abrescia LD, Radolf JD, Furie MB. Outer surface lipoproteins of Borrelia burgdorferi activate vascular endothelium in vitro. Infect Immun Aug;64(8):3180-7, 1996.

Schutzer SE, Coyle PK, Belman AL, Golightly MG, Drulle J, Sequestration of antibody to Borrelia burgdorferi in immune complexes in seronegative Lyme disease. Lancet 1990 Feb 10;335(8685):312-315.

Schutzer SE, Coyle PK, Dunn JJ, Luft BJ, Brunner M, Early and specific antibody response to OspA in Lyme Disease. J Clin Invest Jul;1994(1):454-457, 1994.

Shenep, JL, Flynn PM , Barrett FF, Stidham GL, and Westenkirchner DF, Serial quantitation of endotoxemia and bacteremia during therapy for gram-negative bacterial sepsis. J. Infect. Dis. 157:565-568, 1988.

Shenep, JL, Barton RP, and Mogan KA, Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental gram-negative bacterial sepsis. J. Infect. Dis. 151:1012-1018, 1985.

Shmuklarsky MJ, Boudreau EF, Pang LW, Smith JI, Schneider I, Fleckenstein L, Abdelrahim MM, Canfield CJ, Schuster B, Failure of doxycycline as a causal prophylactic agent against Plasmodium falciparum malaria in healthy nonimmune volunteers.Ann Intern Med 1994 Feb 15;120(4):294-9.

Sigal LH, Immunologic mechanisms in Lyme neuroborreliosis: the potential role of autoimmunity and molecular mimicry, Semin Neurol 1997 Mar;17(1):63-8

Sigal LH, Williams S, A monoclonal antibody to Borrelia burgdorferi flagellin modifies neuroblastoma cell neuritogenesis in vitro: a possible role for autoimmunity in the neuropathy of Lyme disease, Infect Immun 1997 May;65(5):1722-8.

Smirnova OA, Study of cyclic kinetics of immunity by mathematical modeling methods, Kosm Biol Aviakosm Med. 25(5):53-6, 1991.

Spangler SK, Jacobs MR, Apfelbaum PC, MIC and Time-Kill Studies of Antipneumococcal Activity of 118819X (Sanfetrinem) Compared with Those of Other Agents, Antimicrob Agents Chemother 41:141-155, 1997.

Straubinger RK, Straubinger AF, Summers BA, Erb HN, Härter L, Appel MJG, Borrelia burgdorferi induces the production and release of proinflammatory cytokines in canine synovial explant cultures. Infect Immun 66(1):246-258, 1998.

Straubinger RK, PCR-Based Quantification of Borrelia burgdorferi Organisms in Canine Tissues over a 500-Day Postinfection Period. J Clin Microbiol 2000;38:2191.

Tai KF, Ma Y, Weis JJ, 1994. Normal human B lymphocytes and mononuclear cells respond to the mitogenic and cytokine-stimulatory activities of Borrelia burgdorferi and its lipoprotein OspA. Infect Immun Feb;62(2):520-8, 1994.

Thornsberry et al., In vitro activity of cefepime and other antimicrobials: survey of European isolates, J. Antimicrobial Chemother 32, Suppl. B, 55-62, 1993.

van den Berg C, De Neeling AJ, Schot CS, Hustinx WMN, Wemer J, and de Wildt DJ, Delayed antibiotic-induced lysis of Escherichia coli in vitro is correlated with enhancement of LPS release. Scand. J. Infect. Dis. 24:619-627, 1992.

van Deuren, M, van der Ven-Jongekrijg J, Bartelink AK, van Dalen R, Sauerwein RW, and van der Meer JW, Correlation between proin-flammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections. J. Infect. Dis. 172:433Ð439, 1995.

Wagner D private communication, Pharmaceutical Info Div., 777 Scudders Mill Road, Plainsboro, NJ 08536, Tel.: +1 (609) 897 - 2776, Fax: +1 (609) 897 - 6042.

Yim CW, Flynn NM, Fitzgerald FT, Penetration of oral doxycycline into the cerebrospinal fluid of patients with latent or neurosyphilis.Antimicrob Agents Chemother 1985 Aug;28(2):347-8.

Zhang JR, Hardham JM, Barbour AG, Norris SJ, Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes, Cell Apr 18;89(2):275-285, 1997.

Zhang H, Niesel DW, Peterson JW, Gary R, Lipoprotein release by bacteria: potential factor in bacterial pathogenesis, Infect Immun 66(11):5196-5201, 1998.


Version: September 8, 2007.
The address of this page is: http://www.lymenet.de/symptoms/cycles/references.htm
Home page of this site is: http://www.lymenet.de.
Send questions and comment to Joachim Gruber